NCT05640349

Brief Summary

The main objective of this retrospective cohort is to evaluate the impact of the first epidemic wave during lockdown on bacteremia epidemiology in one French University Hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

6 months

First QC Date

December 2, 2022

Last Update Submit

December 6, 2022

Conditions

BacteremiaCatheter-Related Infections

Outcome Measures

Primary Outcomes (1)

  • Epidemiology of bacteriemia,catheter-related infection and contamination

    Describe and compare the incidence and epidemiology of hospital-diagnosed bacteriemia, catheter-related infection and contamination

    Day 0

Secondary Outcomes (2)

  • Characterization of community bacteremia

    Day 0

  • Determined therapeutic actions

    Day 0

Study Arms (2)

Case

Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice during the Covid-19 Pandemic lockdown (between 23/03/2020 and 24/05/2020).

Biological: Positive blood culture

Control

Patients with positive blood culture recorded at the microbiology laboratory of University Hospital of Nice between 23/03/2019 and 24/05/2019.

Biological: Positive blood culture

Interventions

Positive blood cultureBIOLOGICAL

Positive blood culture recorded at the microbiology laboratory of University Hospital of Nic

CaseControl

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of University Hospital of Nice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, 06001, France

Location

MeSH Terms

Conditions

BacteremiaCatheter-Related Infections

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2022

First Posted

December 7, 2022

Study Start

April 15, 2022

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)